Identification of Biomarkers, New Treatments, and Vaccines for COVID-19
Springer International Publishing
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Chapter title |
COVID-19, Coenzyme Q10 and Selenium
|
|---|---|
| Book title |
Advances in Experimental Medicine and Biology
|
| Published in |
Advances in experimental medicine and biology, July 2021
|
| DOI | 10.1007/978-3-030-71697-4_13 |
| Pubmed ID | |
| Book ISBNs |
978-3-03-071696-7, 978-3-03-071697-4
|
| Authors |
Hargreaves, I. R., Mantle, D., I. R. Hargreaves, D. Mantle |
X Demographics
The data shown below were collected from the profiles of 51 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | 6% |
| United Kingdom | 1 | 2% |
| Malaysia | 1 | 2% |
| Australia | 1 | 2% |
| France | 1 | 2% |
| Unknown | 44 | 86% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 46 | 90% |
| Scientists | 3 | 6% |
| Practitioners (doctors, other healthcare professionals) | 2 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 23 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 4 | 17% |
| Librarian | 3 | 13% |
| Student > Doctoral Student | 2 | 9% |
| Student > Bachelor | 2 | 9% |
| Other | 1 | 4% |
| Other | 4 | 17% |
| Unknown | 7 | 30% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 5 | 22% |
| Nursing and Health Professions | 2 | 9% |
| Veterinary Science and Veterinary Medicine | 1 | 4% |
| Unspecified | 1 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 1 | 4% |
| Other | 6 | 26% |
| Unknown | 7 | 30% |
Attention Score in Context
This research output has an Altmetric Attention Score of 39. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 March 2024.
All research outputs
#1,111,234
of 26,499,616 outputs
Outputs from Advances in experimental medicine and biology
#141
of 5,277 outputs
Outputs of similar age
#26,684
of 451,264 outputs
Outputs of similar age from Advances in experimental medicine and biology
#3
of 119 outputs
Altmetric has tracked 26,499,616 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,277 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 451,264 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 119 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.